SlideShare a Scribd company logo
Iron Deficiency Anemia in Pregnancy
Role of IV Ferric Carboxymaltose and
its Impact on Neonatal Outcomes
PAN DGF CME
1st July 2023
Speaker
Dr Anjila Aneja
MD, DNB, MRCOG ,FRCOG (UK), Diploma in Pelvic Endoscopy
Senior Director Obst , Gynae & MAS Gynae at Fortis la Femme
• WHO – 32.4 million pregnant women suffer from anemia worldwide
• 0.8 million women are severely anemic
• 50% cases are attributed to Iron deficiency anemia
• 5,91,000 perinatal deaths and 1,15,000 maternal deaths attributed to iron
deficiency anemia directly or indirectly
• Low SES , High parity, endemic malaria, phytate rich Indian diet, nutritional
deficiencies, helminthic infections and inflammatory and infections ds further
increase the IDA in pregnancy
• Anemia – qualitative or quantitative reduction in the oxygen carrying capacity
of blood usually resulting from reduced hemoglobin that leads to reduced
oxygen supply to peripheral tissues
WHO defines Anemia in pregnancy as
- Hb < 11gm/dl
- PCV < 33%
- PP patients Hb < 10g/dl
Anemia During Pregnancy
Hemoglobin (g/dL)
CDC < 11 ( 1st trimester)
< 10.5 (2nd trimester)
< 11 (3rd trimester)
WHO < 11
WHO classification of severity of anemia in adult females
[ Hemoglobin in g/dL]
Mild Moderate Severe
Non pregnant
women(age >15
years or above)
11–11.9 8–10.9 < 8
Pregnant
women
10–10.9 7–9.9 < 7
Indian J Hematol Blood Transfus. 2018:1-2.
Anemia During Pregnancy: Forming a Consensus
ICMR 10-10.9 7-10 <4
Physiologic (dilutional) Anemia
• Physiologic changes during pregnancy result in dilutional anemia despite an overall increase
in red blood cell mass.
• Plasma volume increases by 10 to 15 percent at 6 to 12 weeks of gestation, expands rapidly
until 30 to 34 weeks, and then plateaus or decreases slightly to term.
• The total gain at term averages 1100 to 1600 mL and results in a total plasma volume of
4700 to 5200 mL, which is 40 to 50 percent above that prior to pregnancy
• The RBC mass also increases, but to a lesser extent (approximately 15 to 25 percent).
• Physiological anemia
- >10 to 11 g/dL
- PCV>30
- RBC count > 3.2million
- RBC morphological normal
Milman N Ann Hematol 2006; 85(9):559-565 Indian J Hematol Blood Transfus. 2018:1-2.
Total Iron requirement in Pregnancy
Total iron requirement during singleton pregnancy: 1000 to 1200 mg.
• The average daily requirement of
iron
• 0.8 mg/d in the first trimester
• 4mg /Day in 2nd trimester
• 6mg/day in 3rd trimester and
increases to even 7.5 mg/day in late
third trimester.
• The average daily absorption from:
Western diet  1–5 mg/day
Indian diet  0.8 - 2 mg/day
Nutritional Deficiencies • Iron, Folic acid, Vitamin B12, Copper, Riboflavin
Hemolysis and abnormal
hemoglobin synthesis
• Thalassemia, Sickle cell anemia
• Malaria
• G6PD deficiency
Blood loss, and defective iron
absorption and metabolism
• Helminthiasis, especially hookworm infestation
• Amoebiasis, Giardiasis, Schistosomiasis
• Bleeding haemorrhoids
• Antepartum haemorrhage
Chronic conditions
• Malignancies, Tuberculosis
• Chronic renal disease including urinary tract infection
• Human Immune deficiency Virus infection
• Chronic rheumatic and rheumatoid disease
Best Practice & Research Clinical Obstetrics and Gynaecology 26 (2012) 3–24
Causes of Anemia in Pregnancy
Indian J Hematol Blood Transfus. 2018:1-2.
Consequences of IDA in Pregnancy
Maternal anemia contributes to 18% of perinatal mortality and 20% of maternal mortality in
South Asian countries including India
Antepartum complications
• Increased risk of
preterm delivery
• Premature rupture of
membranes
• Pre-eclampsia
• Intrauterine Death
• Inter-current infection
• Antepartum
haemorrhage
• Congestive Heart Failure
Fetal outcomes
• Low birth weight
• Prematurity
• Infections
• Congenital
malformation
• Neonatal Anemia
• Abnormal cognitive
development
• Increased risk of
schizophrenia
Intrapartum complications
• Prolonged labour
• Operative delivery
• Fetal distress
• Abruption
Postpartum complication
• PPH
• Puerperal sepsis
• Lactation failure
• Pulmonary thromboembolism
• Subinvolution of uterus
• Post partum depression
Approach to Anemia
MCV <80 MCV 80-100 MCV >100
Microcytic anemia
Serum Iron studies
Ferritin <30
Iron
deficiency
Anemia
Low/normal
iron and
Ferritin with
low TIBS
Suggests a
Component of
Anemia of
Chronic ds
With IDA
Normocytic anemia
Reticulocyte count
Reticulocyte
count <2%
Megloblastic Anemia
Reticulocyte
Count>2%
Mentzer Index
(MCV/RBC)<13
Thalassemia
• Leukemia
• Aplastic anemia
• Pure red cell
aplasia
• Other marrow
failure
• Hemorrhage
• Hemolytic
anemia
Megalocytes& segmented
Neutrophils on PBF
Present
megaloblastic
Absent
Non megaloblastic
• Vitamin B12
• Folate
deficiency
• Drug induced
• Alcohol
• Myelodysplastic
Syndrome
• Liver disease
• Congenital
Bone marrow
failure
Indian J Hematol Blood Transfus. 2018:1-2.
Diagnosis of IDA in Pregnancy: Importance of Serum Ferritin
• Sr. Ferritin: <30 µg/dl to diagnose and treat ID in pregnancy
• Indications of testing serum ferritin in pregnancy:
• Prior to starting iron therapy in patients with known hemoglobinopathy
• Differential diagnoses of microcytic anemia is under evaluation (chronic inflammation,
lead toxicity, sideroblastic anemia)
• Suboptimal response to oral iron
• In non-anemic women at risk of iron depletion: Previous anemia, multiple pregnancy,
teenage pregnancy, pregnancy with high risk of bleeding, consecutive pregnancies
• Preferably prior to parenteral iron therapy to confirm iron deficiency
Normal Carrier
Red Blood cell index Male Female Beta Thal Minor
Mean corpuscular volume
( MCV fl )
89.1+ - 5.01 87.6 +- 5.5 < 80
Mean corpuscular
Haemoglobin
(MCH pg )
30.9+-1.9 30.2+-2.1 <27
Haemoglobin
( Hb g/dl )
12-16gm 11.5-15gm Male – 11.5-15.3 gm
Female 9.1-14gm
Anemia is not a criteria to diagnose Thalassemia
Prevention of Iron Deficiency Anemia
• Iron rich food and avoid substances which interfere with iron absorption
• Food fortification with iron ( wheat flour ( salt )
• Screening of adolescent girls and supplementation of Iron wherever is required
• Cooking in Iron utensils
• Hookworm and malaria chemoprophylaxis
• Adequate birth spacing
Iron Prophylaxis
During
Pregnancy
Postpartum
Prophylaxis Treatment
WHO Daily 60mg of iron + 400ug
Of folic acid till term
Daily 120mg of iron and
400ug of folic acid till term
Daily 60mg of iron + 400ug
Of folicx 3 months
MoHFW
Daily 100mg of iron +
500ug folic acid for 100
days
Starting after first
trimester at 14-16 weeks
of gestation
• Mild anemia – 2 IFA /day x
100 days
• Moderate anemia –
Parentral iron + oral folic
acid
Daily 100mg of iron + 500ug
folic acidx 6 months
Oral Iron Preparation
Preparation Total iron
(mg/tab
Elemental iron
(mg/tab)
% elemental Iron
Ferrous fumarate 200 66 33 High tolerance
bioavaiability
Ferrous sulphate hydrous
Ferrous Sulphate Dessicated
300
200
60
65
20
32
Most common
Least expensive
Ferrous succinate 100 35 35
Ferrous ammonium citrate 160 30 18
Ferrous Ascorbate 730 100 14 Superior
High elemental iron
Sodium Ferederate 231 33 14
Carbonyl Iron 100 98 98
Response to Oral Iron therapy
5-7 days Reticulocyte count increases ( O.2%/day
2 – 3 weeks Hb increases by 0.8 – 1gm/dl/week
All parameters MCV , MCH , MCHC improve
6-8 weeks Hb – normal range
Serum Ferritin Increases
PBF – normocytic normochromic
Clinical Improvement Optimal response > 2g in 2 weeks
Copyrights apply
Role of Parenteral Iron Therapy
in IDA
Indian J Hematol Blood Transfus. 2018:1-2.
Indicators of Parenteral Iron Therapy
IV iron therapy is superior to oral iron in terms of speed and absolute extent of
rise in hemoglobin and replenishment of iron stores
Indications
• Failure of oral iron therapy
• Non-compliance or intolerance to oral iron
• Late second or third trimester with moderate to
severe IDA
• Rapid rectification of anemia and repletion of iron
stores expected
• Malabsorption (e.g. Bowel-resection/Celiac disease)
• Bleeding diathesis when hemorrhage is likely to
continue
Contraindications
• Gestation period < 12 weeks
• Lack of facilities for resuscitation
• Known history of anaphylaxis or
reactions to parenteral iron
• Known state of iron overload
Arch Gynecol Obstet. 2017 Dec;296(6):1229-1234
Iron Oxyhydroxide
core
Carbohydrate
shell – stabilizes the molecule
and
slows release of elemental iron
Parenteral Iron Preparations
Iron Dextran
Risk of anaphylaxis
Iron Sucrose
Multiple doses; longer time
of administration
Ferric Carboxymaltose
High amount of iron in single
dose with low risk of
hypersensitivity reactions
Iron Isomaltoside
Contains reduced dextran,
more labile iron v/s FCM,
Low clinical evidence
Parenteral
iron
Selecting Ideal Parenteral Iron
Property Ideal Iron dextran Iron sucrose Ferric carboxymaltose
Type I (robust) I (robust) II (semi-robust) I (robust)
Mol wt >100 kD >100 kD 34-60 kD 150 kD
Complex stability High High Moderate High
Half life Long 3-4 days 6 hours 16 hours
pH Neutral Neutral High Near-Neutral
Osmolality Isotonic Isotonic High Isotonic
Antigenicity Low High Low Low
Test dose No Yes No No
Time for injection Short 4 - 6 h for 20mg/kg 3.5 h for 7mg/kg 15 min for 1000mg
Max dose High 20mg/kg 600 mg/week 1000 mg/infusion
Arzneimittelforschung 2010;60(6a):345–353; Arzneimittelforschung 2010;60(6a):399–412
Properties of an Ideal Parenteral Iron
Critical Attributes of FCM
Type 1 (robust)
Parenteral iron
Not associated with
dextran-induced
hypersensitivity
Can be administered
in much higher doses
Short infusion time
(minimum 15
minutes)
Iron is released slowly,
avoiding toxicity and
oxidative stress
Structure similar to
ferritin, deposited
easily in RE cells
Test dose is not
required
Low immunogenic
potential
Qualities of FCM are best suited for
real-life clinical usage
FCM – Dosage Calculation and Administration
In most of Indian pregnant
women 1000 to 1500 mg is
well suited
Ferric carboxymaltose summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5910/smpc/print
Administration of FCM in Routine Clinical Practice
Dilution Duration
Ferric carboxymaltose summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5910/smpc/print
• Mix Inj FCM 1000mg in 250 ml of saline and give
over 15 minutes
• Mix inj FCM 500mg in 100ml of saline and give
over 6 minutes
• Monitor Vitals for 45 minutes
Clinical Evidence:
FCM in Management of IDA
During Pregnancy
Global Evidence of FCM in Pregnancy
Geography
Total no. of
studies
Countries
No. of pregnant
women treated
with FCM
Highest Hb rise
(g/dL)
Highest Ferritin
rise (µg/L)
Global Studies Ten (#10) Switzerland,
United Kingdom,
Australia, Spain,
Korea, Australia,
UAE, Turkey
2495 3.6 188
Indian Studies Seventeen (#17) India 1326 5.5 180
Current evidence highlighted data of FCM usage in 3821 pregnant women with
maximum Hb rise of 5.5 g/dL and ferritin rise of 180 µg/L
Naqash A et al. BMC Womens Health. 2018; 18(1):6 Jose et al. BMC Pregnancy and Childbirth (2019) 19:54
Important Clinical Studies of FCM in Pregnancy
Sr.
no.
Study
Patient
population
In FCM
group
Follow Up
(Weeks)
Hb rise (g/dL)
Ferritin rise
(µg/L)
Any Serious
Adverse Event
1 Maheshwari et al 100 4 3.6 47 No
2 Mishra et al 108 3 2.1 168 No
3 Naqash et al 100 4 5.5 31 No
4 Agrawal et al 50 3 3 65 No
5 Gandotra et al 100 2 2.9 65 No
6 Mahaur et al 50 6 2.6 112 No
7 Patel et al 50 3 2.6 101 No
1. Maheshwari et al. Indian J Obstet Gynecol Res. 2017;4(1):96-100.
2. Mishra V et al. Journal of Nepal Health Research Council. 2017 Sep 8;15(2):96-9
3. Naqash A et al. BMC Womens Health. 2018; 18(1):6
4. Agrawal D et al. J Reprod Contracept Obstet Gynecol. 2019 Jun;8(6):2280-2285
5. Gandotra N et al. Int J Res Med Sci. 2020 Oct;8(10):3539-3542
6. Mahaur et al. International Journal of Clinical Obstetrics and Gynaecology 2020; 4(3):
148-152
7. Patel A et al. Int J Reprod Contracept Obstet Gynecol. 2020 Jun;9(6):2437-2441
Inclusion Criteria Intervention Parameters
RCT
100 Pregnant women
diagnosed with moderate to
severe IDA
FCM (n=50): Dose as per
calculated iron requirement
Iron Sucrose (ISC) (n=50):
Dose as per calculated iron
requirement
Rise in Hb from baseline after
12 weeks
Jose et al. BMC Pregnancy and Childbirth (2019) 19:54
Indian RCT from AIIMS, New Delhi
Rise in hemoglobin at 12 weeks from baseline
Jose et al. BMC Pregnancy and Childbirth (2019) 19:54
• Treatment with FCM resulted in rapid replenishment of iron stores with significantly
higher Hb rise over a 12 week period.
• Convenient dosing with lesser number of total doses to complete the treatment will
lead to better compliance
Indian RCT from AIIMS, New Delhi: Results
The mean rise in Hb at 12 weeks
was significantly higher in FCM
group than Iron Sucrose group
(29 g/L vs 22 g/L; p < 0.001)
Insights from Indian Real World Evidence
50 pregnant women in 2nd and 3rd trimester received a single IV infusion of FCM 1000 mg over 15 minutes
Significant increase in Hb of 2.24
g/dl over 4 weeks
Significant improvement in fatigue
score at 4 weeks
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2021 Dec 1;10(12):4402-7.
Insights from Largest Indian Real World Evidence
Indian real world evidence of 271 pregnant women receiving FCM of ~1000 mg
Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
• 271 pregnant women in 2nd and 3rd trimester
of pregnancy received FCM (Mean dose
∼1000 mg)
• Significant increase in Hb was noted in just
20 days!
• Significant increase in Hb of 4.23 g/dL was
noted in Severe Anemia
Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
Insights from Largest Indian Real World Evidence: Efficacy
Single large dose administration of FCM led to rapid rise of Hb in moderate-to-severe anemia
during pregnancy in a real-life scenario.
Insights from Largest Indian Real World Evidence: Safety
• Adverse events reported in just 4% of pregnant women! (Most common – rash
and itching)
• No hypersensitivity reactions observed in any pregnant women
• Continuous monitoring of vitals and oxygen saturation up to 45 min did not
report any negative safety signals
Absence of any hypersensitivity reactions and no negative safety signal in vital
parameters observed during continuous monitoring supports excellent safety
of FCM in moderate-to-severe anemia during pregnancy in a real-life scenario
Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
• Data of 162 newborns born to mothers who had received FCM in
pregnancy was analyzed in terms of:
• Mean gestational age at delivery
• Mean birth weight
• Apgar score
• Stillbirth, perinatal, and early neonatal mortality rates
• Requirement of hospitalization
No adverse effects in terms of perinatal and neonatal outcomes were observed
in newborns of women who received FCM during pregnancy
Insights from Largest Indian Real World Evidence: Neonatal Outcomes
Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
Global Clinical Studies: FCM and Neonatal Outcomes
Christoph et al. Journal of perinatal medicine. 2012 Sep 1;40(5):469-74
• 206 pregnant women: Treated either with
FCM or iron sucrose
• Among women treated with FCM, no signs of
negative effects of the FCM treatment were
detected on the fetus or newborn babies.
• 95 pregnant women: Treated with FCM; 83
women among them received single dose of
FCM 1000mg
• Neonatal outcomes (week of pregnancy at
delivery, Apgar scores, and birth weight) were
NOT adversely affected due to FCM
Aporta Rodriguez et al. Obstetrics and gynecology international. 2016 Jan 1;2016
Global Clinical Studies: Neonatal Outcomes
Breymann et al. Journal of perinatal medicine. 2017;45(4):443-53
• 126 pregnant women: Treated with FCM
(1000 – 1500 mg)
• No complications associated with FCM
treatment of the mothers were evident in the
newborns
• 83 pregnant women: Treated with FCM (1000
mg single dose)
• FCM administered to pregnant women did
not affect fetal outcomes (Apgar scores,
weight, length or head circumference of the
baby, neonatal resuscitation or
complications)
Khalafallah A et al. InSeminars in hematology. 2018; 55(4):223-234
Mild anemia (Hb 10-10.9g/dL) & Moderate anemia ( 7-9.9 g/dL)
First level of treatment
Two tablets of iron and folic acid tablet (100 mg elemental
iron and 500 mcg folic acid) daily for 6 months
Parental iron (IV Iron Sucrose or FCM) may be considered as
the first line of management in pregnant women who are
detected to be anemic late in pregnancy or in whom
compliance is likely to be low (high chance of lost to follow-
up).
If no improvement,
after first level of
treatment
• Referral to higher health facility
• The case may be managed with IV Iron Sucrose/Ferric
Carboxymaltose
Anemia Mukt Bharat Guidelines 2018
Anemia management protocol for Pregnant women
Severe anemia (Hb 5-6.9 g/dL)
First level of
treatment
Immediate hospitalization if it is the third
trimester of pregnancy where round-the-clock
specialist care is available
The treatment will be done using IV Iron
Sucrose/Ferric Carboxymaltose by the medical
officer.
Anemia Mukt Bharat Guidelines 2018
Anemia management protocol for Pregnant women
FCM in Management of IDA in Pregnancy: Conclusion
• FCM is superior to oral iron and other IV irons in terms of speed and absolute extent of rise
in hemoglobin and replenishment of iron stores
• FCM administration does not require test dose; not associated with dextran-induced
hypersensitivity; can be administered safely in a higher dose in short duration
• FCM infusion during pregnancy is not associated with severe hypersensitivity reactions and
negative safety signals in vital parameters
• Substantial Global and Indian evidence encompassing 3821 pregnant women with maximum
Hb rise of 5.5 g/dL and ferritin rise of 180 µg/L
• FCM administered to pregnant women for treatment of IDA did not adversely affect
neonatal outcomes (Apgar score, birth weight, mortality rates, hospitalization rates, etc.)
Iron Deficiency Anemia in PregnancyRole of IV Ferric Carboxymaltose andits Impact on Neonatal Outcomes : Dr Sharda Jain

More Related Content

What's hot

Practical approach to amenorrhea warda
Practical approach to amenorrhea wardaPractical approach to amenorrhea warda
Practical approach to amenorrhea warda
Osama Warda
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
NARENDRA C MALHOTRA
 
Femoston vs tibolone hormone replacement therapy 1.5.15
Femoston vs tibolone hormone replacement therapy 1.5.15Femoston vs tibolone hormone replacement therapy 1.5.15
Femoston vs tibolone hormone replacement therapy 1.5.15
Dr Nupur Gupta High Risk Obstetrician
 
Pcos
PcosPcos
What is 40 : 1 In management of Dr. Jyoti Agarwal Dr. Sharda Jain Dr. Jyo...
What is 40 : 1 In management of Dr. Jyoti Agarwal  Dr. Sharda Jain  Dr. Jyo...What is 40 : 1 In management of Dr. Jyoti Agarwal  Dr. Sharda Jain  Dr. Jyo...
What is 40 : 1 In management of Dr. Jyoti Agarwal Dr. Sharda Jain Dr. Jyo...
Lifecare Centre
 
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementRecent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Atef Darwish
 
Inositol and PCOS - Seminar Presentation
Inositol and PCOS - Seminar PresentationInositol and PCOS - Seminar Presentation
Inositol and PCOS - Seminar Presentation
Wendy Thompson
 
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
Lifecare Centre
 
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Aboubakr Elnashar
 
Low dose aspirin use during pregnancy 2021
Low dose aspirin use during pregnancy 2021Low dose aspirin use during pregnancy 2021
Low dose aspirin use during pregnancy 2021
憶 楊
 
Thrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy LossThrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy Loss
Marwan Alhalabi
 
Role of progestogen in miscarriage
Role of progestogen in miscarriageRole of progestogen in miscarriage
Role of progestogen in miscarriage
chaimingcheng
 
Update on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacyUpdate on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacy
Dr.Laxmi Agrawal Shrikhande
 
Parentaral Iron Therapy Freash Thinking
Parentaral Iron Therapy Freash ThinkingParentaral Iron Therapy Freash Thinking
Parentaral Iron Therapy Freash Thinking
veerendrakumar cm
 
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
Sujoy Dasgupta
 
Calcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in PregnancyCalcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in Pregnancy
Sujoy Dasgupta
 
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
Lifecare Centre
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
Bharati Dhorepatil
 
Newer Predictors of Preeclampsia
Newer Predictors of PreeclampsiaNewer Predictors of Preeclampsia
Newer Predictors of Preeclampsia
Dr Anusha Rao P
 
hyperprolactinemia
hyperprolactinemiahyperprolactinemia
hyperprolactinemia
Sreelasya Kakarla
 

What's hot (20)

Practical approach to amenorrhea warda
Practical approach to amenorrhea wardaPractical approach to amenorrhea warda
Practical approach to amenorrhea warda
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
Femoston vs tibolone hormone replacement therapy 1.5.15
Femoston vs tibolone hormone replacement therapy 1.5.15Femoston vs tibolone hormone replacement therapy 1.5.15
Femoston vs tibolone hormone replacement therapy 1.5.15
 
Pcos
PcosPcos
Pcos
 
What is 40 : 1 In management of Dr. Jyoti Agarwal Dr. Sharda Jain Dr. Jyo...
What is 40 : 1 In management of Dr. Jyoti Agarwal  Dr. Sharda Jain  Dr. Jyo...What is 40 : 1 In management of Dr. Jyoti Agarwal  Dr. Sharda Jain  Dr. Jyo...
What is 40 : 1 In management of Dr. Jyoti Agarwal Dr. Sharda Jain Dr. Jyo...
 
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementRecent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
 
Inositol and PCOS - Seminar Presentation
Inositol and PCOS - Seminar PresentationInositol and PCOS - Seminar Presentation
Inositol and PCOS - Seminar Presentation
 
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...AMH OVARIAN RESERVEMARKER Dr  Jyoti Bhasker ,Dr. Sharda Jain  Dr. Jyoti Ag...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
 
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013
 
Low dose aspirin use during pregnancy 2021
Low dose aspirin use during pregnancy 2021Low dose aspirin use during pregnancy 2021
Low dose aspirin use during pregnancy 2021
 
Thrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy LossThrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy Loss
 
Role of progestogen in miscarriage
Role of progestogen in miscarriageRole of progestogen in miscarriage
Role of progestogen in miscarriage
 
Update on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacyUpdate on iron deficiency anemia in pregnacy
Update on iron deficiency anemia in pregnacy
 
Parentaral Iron Therapy Freash Thinking
Parentaral Iron Therapy Freash ThinkingParentaral Iron Therapy Freash Thinking
Parentaral Iron Therapy Freash Thinking
 
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)
 
Calcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in PregnancyCalcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in Pregnancy
 
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...PCOS Treatment Guidelines  &  Review of  Newer Medical Treatment in Infertili...
PCOS Treatment Guidelines & Review of Newer Medical Treatment in Infertili...
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
 
Newer Predictors of Preeclampsia
Newer Predictors of PreeclampsiaNewer Predictors of Preeclampsia
Newer Predictors of Preeclampsia
 
hyperprolactinemia
hyperprolactinemiahyperprolactinemia
hyperprolactinemia
 

Similar to Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its Impact on Neonatal Outcomes : Dr Sharda Jain

ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
Akebom Gebremichael
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
Dr Debashis Nanda
 
Anemia in pregnancy by oouth unit d medical students o&g
Anemia in pregnancy by oouth unit d medical students o&gAnemia in pregnancy by oouth unit d medical students o&g
Anemia in pregnancy by oouth unit d medical students o&g
Tolulope Balogun
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryan
Ryan Mulyana
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryan
Ryan Mulyana
 
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptxANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
Shabnam Shaikh
 
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-BahlaIron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
AshrafAlbhla1
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
Dr. Ravi Prakash
 
Anemia during pregnancy
Anemia during pregnancy Anemia during pregnancy
Anemia during pregnancy
Mahmoud zakherah
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
chaimingcheng
 
Anemia
Anemia Anemia
Anemia
PNK SINGH
 
Anemia 130809044630-phpapp01
Anemia 130809044630-phpapp01Anemia 130809044630-phpapp01
Anemia 130809044630-phpapp01
rupesh giri
 
Anemia
AnemiaAnemia
Anemia in pregnancy -2010 -Eyasu.pdf
Anemia in pregnancy -2010 -Eyasu.pdfAnemia in pregnancy -2010 -Eyasu.pdf
Anemia in pregnancy -2010 -Eyasu.pdf
keshisisay
 
Anemia Panel - New.pptx
Anemia Panel - New.pptxAnemia Panel - New.pptx
Anemia Panel - New.pptx
Drneelimayadav2
 
Anemia
Anemia Anemia
Anemia
Johny Wilbert
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Anemia in Pregnancy
Anemia in PregnancyAnemia in Pregnancy
Anemia in Pregnancy
Kerryn Rohit
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
Mohammad Ihmeidan
 
Anemia
AnemiaAnemia

Similar to Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its Impact on Neonatal Outcomes : Dr Sharda Jain (20)

ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
 
Anemia in pregnancy by oouth unit d medical students o&g
Anemia in pregnancy by oouth unit d medical students o&gAnemia in pregnancy by oouth unit d medical students o&g
Anemia in pregnancy by oouth unit d medical students o&g
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryan
 
Anemia in pregnancy ryan
Anemia in pregnancy ryanAnemia in pregnancy ryan
Anemia in pregnancy ryan
 
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptxANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
ANEMIA IN PREGNANCY BY DR SHABNAM NAZ.pptx
 
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-BahlaIron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
Iron Deficiency Anemia (IPD) by Ashraf Abdulkarim Al-Bahla
 
Anaemia in pregnancy
Anaemia in pregnancyAnaemia in pregnancy
Anaemia in pregnancy
 
Anemia during pregnancy
Anemia during pregnancy Anemia during pregnancy
Anemia during pregnancy
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
 
Anemia
Anemia Anemia
Anemia
 
Anemia 130809044630-phpapp01
Anemia 130809044630-phpapp01Anemia 130809044630-phpapp01
Anemia 130809044630-phpapp01
 
Anemia
AnemiaAnemia
Anemia
 
Anemia in pregnancy -2010 -Eyasu.pdf
Anemia in pregnancy -2010 -Eyasu.pdfAnemia in pregnancy -2010 -Eyasu.pdf
Anemia in pregnancy -2010 -Eyasu.pdf
 
Anemia Panel - New.pptx
Anemia Panel - New.pptxAnemia Panel - New.pptx
Anemia Panel - New.pptx
 
Anemia
Anemia Anemia
Anemia
 
Iron deficiency anemia
Iron deficiency anemiaIron deficiency anemia
Iron deficiency anemia
 
Anemia in Pregnancy
Anemia in PregnancyAnemia in Pregnancy
Anemia in Pregnancy
 
Anemia in pregnancy
Anemia in pregnancyAnemia in pregnancy
Anemia in pregnancy
 
Anemia
AnemiaAnemia
Anemia
 

More from Lifecare Centre

The Newer Concepts In Endometriosis Management : Dr Sharda Jain
The Newer Concepts In Endometriosis  Management : Dr Sharda JainThe Newer Concepts In Endometriosis  Management : Dr Sharda Jain
The Newer Concepts In Endometriosis Management : Dr Sharda Jain
Lifecare Centre
 
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
Lifecare Centre
 
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
Lifecare Centre
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
Lifecare Centre
 
Liver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda JainLiver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda Jain
Lifecare Centre
 
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
Lifecare Centre
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
Lifecare Centre
 
Strategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PARTStrategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PART
Lifecare Centre
 
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
Lifecare Centre
 
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda JainVaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
Lifecare Centre
 
How to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda JainHow to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda Jain
Lifecare Centre
 
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda JainSOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
Lifecare Centre
 
White Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda JainWhite Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda Jain
Lifecare Centre
 
White Coat hypertension Why it is Important? : Dr Sharda Jain
White Coat hypertension Why it is  Important? : Dr Sharda JainWhite Coat hypertension Why it is  Important? : Dr Sharda Jain
White Coat hypertension Why it is Important? : Dr Sharda Jain
Lifecare Centre
 
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda JainUnderstanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Lifecare Centre
 
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda JainKnow Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Lifecare Centre
 
Still Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainStill Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda Jain
Lifecare Centre
 
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
Lifecare Centre
 
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
Lifecare Centre
 
CMV UPDATE Few solid facts about cytomegalovirus (CMV) Infection & New devel...
CMV UPDATE Few solid facts  about cytomegalovirus (CMV) Infection & New devel...CMV UPDATE Few solid facts  about cytomegalovirus (CMV) Infection & New devel...
CMV UPDATE Few solid facts about cytomegalovirus (CMV) Infection & New devel...
Lifecare Centre
 

More from Lifecare Centre (20)

The Newer Concepts In Endometriosis Management : Dr Sharda Jain
The Newer Concepts In Endometriosis  Management : Dr Sharda JainThe Newer Concepts In Endometriosis  Management : Dr Sharda Jain
The Newer Concepts In Endometriosis Management : Dr Sharda Jain
 
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...The Newer Concepts  forReduced Surgery to preserve fertility in Endometrios...
The Newer Concepts for Reduced Surgery to preserve fertility in Endometrios...
 
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...Anemia Free India Gynaecologist  to focuss on *12gm Haemoglobin at Delivery I...
Anemia Free India Gynaecologist to focuss on *12gm Haemoglobin at Delivery I...
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
Liver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda JainLiver Dialogue for Gynaecologists : Dr Sharda Jain
Liver Dialogue for Gynaecologists : Dr Sharda Jain
 
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...National Tuberculosis elimination programme (NIKSHAY)Big Challenge to GOI : ...
National Tuberculosis elimination programme (NIKSHAY) Big Challenge to GOI : ...
 
Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3Innovations & Breakthrough in IVF PART 3
Innovations & Breakthrough in IVF PART 3
 
Strategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PARTStrategies for Improving Success Rates in ART PART
Strategies for Improving Success Rates in ART PART
 
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
20 Simple ways for the Indian public to save water on World Water Day : Dr Sh...
 
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda JainVaccination during Pregnancy & its Importance : Dr Sharda Jain
Vaccination during Pregnancy & its Importance : Dr Sharda Jain
 
How to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda JainHow to optimize success rates in ART? : Dr Sharda Jain
How to optimize success rates in ART? : Dr Sharda Jain
 
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda JainSOCIALEGG FREEZING : Dr Poorva Bhargav  and Dr Sharda Jain
SOCIALEGG FREEZING : Dr Poorva Bhargav and Dr Sharda Jain
 
White Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda JainWhite Coat Hypertension During Pregnancy : Dr Sharda Jain
White Coat Hypertension During Pregnancy : Dr Sharda Jain
 
White Coat hypertension Why it is Important? : Dr Sharda Jain
White Coat hypertension Why it is  Important? : Dr Sharda JainWhite Coat hypertension Why it is  Important? : Dr Sharda Jain
White Coat hypertension Why it is Important? : Dr Sharda Jain
 
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda JainUnderstanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
Understanding Blood Pressure Reading During Pregnancy : Dr Sharda Jain
 
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda JainKnow Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
Know Your Blood Pressure Understanding Blood Pressure Reading : Dr Sharda Jain
 
Still Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda JainStill Birth:An Update : Dr Sharda Jain
Still Birth:An Update : Dr Sharda Jain
 
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...IRON DEFICIENCY ANEMIA  OVERVIEW  WITH FOCUS ON PARENTRAL IRON THERAPY  : Dr ...
IRON DEFICIENCY ANEMIA OVERVIEW WITH FOCUS ON PARENTRAL IRON THERAPY : Dr ...
 
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
CHECK LIST FOR ART SPECIALIST BEFORE IVF-ICSI FOR PATIENTS SEEKING IVF -ICSI ...
 
CMV UPDATE Few solid facts about cytomegalovirus (CMV) Infection & New devel...
CMV UPDATE Few solid facts  about cytomegalovirus (CMV) Infection & New devel...CMV UPDATE Few solid facts  about cytomegalovirus (CMV) Infection & New devel...
CMV UPDATE Few solid facts about cytomegalovirus (CMV) Infection & New devel...
 

Recently uploaded

Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Vivekanand Anglo Vedic Academy
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
GeorgeMilliken2
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
Krassimira Luka
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Denish Jangid
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
imrankhan141184
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Nguyen Thanh Tu Collection
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
JomonJoseph58
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
haiqairshad
 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
deepaannamalai16
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
zuzanka
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
giancarloi8888
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
TechSoup
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 

Recently uploaded (20)

Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDFLifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
Lifelines of National Economy chapter for Class 10 STUDY MATERIAL PDF
 
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
What is Digital Literacy? A guest blog from Andy McLaughlin, University of Ab...
 
Temple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation resultsTemple of Asclepius in Thrace. Excavation results
Temple of Asclepius in Thrace. Excavation results
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
 
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
Traditional Musical Instruments of Arunachal Pradesh and Uttar Pradesh - RAYH...
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
Stack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 MicroprocessorStack Memory Organization of 8086 Microprocessor
Stack Memory Organization of 8086 Microprocessor
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
 
Standardized tool for Intelligence test.
Standardized tool for Intelligence test.Standardized tool for Intelligence test.
Standardized tool for Intelligence test.
 
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptxRESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
RESULTS OF THE EVALUATION QUESTIONNAIRE.pptx
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Walmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdfWalmart Business+ and Spark Good for Nonprofits.pdf
Walmart Business+ and Spark Good for Nonprofits.pdf
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 

Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its Impact on Neonatal Outcomes : Dr Sharda Jain

  • 1. Iron Deficiency Anemia in Pregnancy Role of IV Ferric Carboxymaltose and its Impact on Neonatal Outcomes PAN DGF CME 1st July 2023
  • 2. Speaker Dr Anjila Aneja MD, DNB, MRCOG ,FRCOG (UK), Diploma in Pelvic Endoscopy Senior Director Obst , Gynae & MAS Gynae at Fortis la Femme
  • 3. • WHO – 32.4 million pregnant women suffer from anemia worldwide • 0.8 million women are severely anemic • 50% cases are attributed to Iron deficiency anemia • 5,91,000 perinatal deaths and 1,15,000 maternal deaths attributed to iron deficiency anemia directly or indirectly • Low SES , High parity, endemic malaria, phytate rich Indian diet, nutritional deficiencies, helminthic infections and inflammatory and infections ds further increase the IDA in pregnancy
  • 4. • Anemia – qualitative or quantitative reduction in the oxygen carrying capacity of blood usually resulting from reduced hemoglobin that leads to reduced oxygen supply to peripheral tissues WHO defines Anemia in pregnancy as - Hb < 11gm/dl - PCV < 33% - PP patients Hb < 10g/dl
  • 5. Anemia During Pregnancy Hemoglobin (g/dL) CDC < 11 ( 1st trimester) < 10.5 (2nd trimester) < 11 (3rd trimester) WHO < 11 WHO classification of severity of anemia in adult females [ Hemoglobin in g/dL] Mild Moderate Severe Non pregnant women(age >15 years or above) 11–11.9 8–10.9 < 8 Pregnant women 10–10.9 7–9.9 < 7 Indian J Hematol Blood Transfus. 2018:1-2. Anemia During Pregnancy: Forming a Consensus ICMR 10-10.9 7-10 <4
  • 6. Physiologic (dilutional) Anemia • Physiologic changes during pregnancy result in dilutional anemia despite an overall increase in red blood cell mass. • Plasma volume increases by 10 to 15 percent at 6 to 12 weeks of gestation, expands rapidly until 30 to 34 weeks, and then plateaus or decreases slightly to term. • The total gain at term averages 1100 to 1600 mL and results in a total plasma volume of 4700 to 5200 mL, which is 40 to 50 percent above that prior to pregnancy • The RBC mass also increases, but to a lesser extent (approximately 15 to 25 percent). • Physiological anemia - >10 to 11 g/dL - PCV>30 - RBC count > 3.2million - RBC morphological normal
  • 7. Milman N Ann Hematol 2006; 85(9):559-565 Indian J Hematol Blood Transfus. 2018:1-2. Total Iron requirement in Pregnancy Total iron requirement during singleton pregnancy: 1000 to 1200 mg. • The average daily requirement of iron • 0.8 mg/d in the first trimester • 4mg /Day in 2nd trimester • 6mg/day in 3rd trimester and increases to even 7.5 mg/day in late third trimester. • The average daily absorption from: Western diet  1–5 mg/day Indian diet  0.8 - 2 mg/day
  • 8. Nutritional Deficiencies • Iron, Folic acid, Vitamin B12, Copper, Riboflavin Hemolysis and abnormal hemoglobin synthesis • Thalassemia, Sickle cell anemia • Malaria • G6PD deficiency Blood loss, and defective iron absorption and metabolism • Helminthiasis, especially hookworm infestation • Amoebiasis, Giardiasis, Schistosomiasis • Bleeding haemorrhoids • Antepartum haemorrhage Chronic conditions • Malignancies, Tuberculosis • Chronic renal disease including urinary tract infection • Human Immune deficiency Virus infection • Chronic rheumatic and rheumatoid disease Best Practice & Research Clinical Obstetrics and Gynaecology 26 (2012) 3–24 Causes of Anemia in Pregnancy
  • 9. Indian J Hematol Blood Transfus. 2018:1-2. Consequences of IDA in Pregnancy Maternal anemia contributes to 18% of perinatal mortality and 20% of maternal mortality in South Asian countries including India Antepartum complications • Increased risk of preterm delivery • Premature rupture of membranes • Pre-eclampsia • Intrauterine Death • Inter-current infection • Antepartum haemorrhage • Congestive Heart Failure Fetal outcomes • Low birth weight • Prematurity • Infections • Congenital malformation • Neonatal Anemia • Abnormal cognitive development • Increased risk of schizophrenia Intrapartum complications • Prolonged labour • Operative delivery • Fetal distress • Abruption Postpartum complication • PPH • Puerperal sepsis • Lactation failure • Pulmonary thromboembolism • Subinvolution of uterus • Post partum depression
  • 10. Approach to Anemia MCV <80 MCV 80-100 MCV >100 Microcytic anemia Serum Iron studies Ferritin <30 Iron deficiency Anemia Low/normal iron and Ferritin with low TIBS Suggests a Component of Anemia of Chronic ds With IDA Normocytic anemia Reticulocyte count Reticulocyte count <2% Megloblastic Anemia Reticulocyte Count>2% Mentzer Index (MCV/RBC)<13 Thalassemia • Leukemia • Aplastic anemia • Pure red cell aplasia • Other marrow failure • Hemorrhage • Hemolytic anemia Megalocytes& segmented Neutrophils on PBF Present megaloblastic Absent Non megaloblastic • Vitamin B12 • Folate deficiency • Drug induced • Alcohol • Myelodysplastic Syndrome • Liver disease • Congenital Bone marrow failure
  • 11. Indian J Hematol Blood Transfus. 2018:1-2. Diagnosis of IDA in Pregnancy: Importance of Serum Ferritin • Sr. Ferritin: <30 µg/dl to diagnose and treat ID in pregnancy • Indications of testing serum ferritin in pregnancy: • Prior to starting iron therapy in patients with known hemoglobinopathy • Differential diagnoses of microcytic anemia is under evaluation (chronic inflammation, lead toxicity, sideroblastic anemia) • Suboptimal response to oral iron • In non-anemic women at risk of iron depletion: Previous anemia, multiple pregnancy, teenage pregnancy, pregnancy with high risk of bleeding, consecutive pregnancies • Preferably prior to parenteral iron therapy to confirm iron deficiency
  • 12. Normal Carrier Red Blood cell index Male Female Beta Thal Minor Mean corpuscular volume ( MCV fl ) 89.1+ - 5.01 87.6 +- 5.5 < 80 Mean corpuscular Haemoglobin (MCH pg ) 30.9+-1.9 30.2+-2.1 <27 Haemoglobin ( Hb g/dl ) 12-16gm 11.5-15gm Male – 11.5-15.3 gm Female 9.1-14gm Anemia is not a criteria to diagnose Thalassemia
  • 13. Prevention of Iron Deficiency Anemia • Iron rich food and avoid substances which interfere with iron absorption • Food fortification with iron ( wheat flour ( salt ) • Screening of adolescent girls and supplementation of Iron wherever is required • Cooking in Iron utensils • Hookworm and malaria chemoprophylaxis • Adequate birth spacing
  • 14. Iron Prophylaxis During Pregnancy Postpartum Prophylaxis Treatment WHO Daily 60mg of iron + 400ug Of folic acid till term Daily 120mg of iron and 400ug of folic acid till term Daily 60mg of iron + 400ug Of folicx 3 months MoHFW Daily 100mg of iron + 500ug folic acid for 100 days Starting after first trimester at 14-16 weeks of gestation • Mild anemia – 2 IFA /day x 100 days • Moderate anemia – Parentral iron + oral folic acid Daily 100mg of iron + 500ug folic acidx 6 months
  • 15. Oral Iron Preparation Preparation Total iron (mg/tab Elemental iron (mg/tab) % elemental Iron Ferrous fumarate 200 66 33 High tolerance bioavaiability Ferrous sulphate hydrous Ferrous Sulphate Dessicated 300 200 60 65 20 32 Most common Least expensive Ferrous succinate 100 35 35 Ferrous ammonium citrate 160 30 18 Ferrous Ascorbate 730 100 14 Superior High elemental iron Sodium Ferederate 231 33 14 Carbonyl Iron 100 98 98
  • 16. Response to Oral Iron therapy 5-7 days Reticulocyte count increases ( O.2%/day 2 – 3 weeks Hb increases by 0.8 – 1gm/dl/week All parameters MCV , MCH , MCHC improve 6-8 weeks Hb – normal range Serum Ferritin Increases PBF – normocytic normochromic Clinical Improvement Optimal response > 2g in 2 weeks
  • 18. Role of Parenteral Iron Therapy in IDA
  • 19. Indian J Hematol Blood Transfus. 2018:1-2. Indicators of Parenteral Iron Therapy IV iron therapy is superior to oral iron in terms of speed and absolute extent of rise in hemoglobin and replenishment of iron stores Indications • Failure of oral iron therapy • Non-compliance or intolerance to oral iron • Late second or third trimester with moderate to severe IDA • Rapid rectification of anemia and repletion of iron stores expected • Malabsorption (e.g. Bowel-resection/Celiac disease) • Bleeding diathesis when hemorrhage is likely to continue Contraindications • Gestation period < 12 weeks • Lack of facilities for resuscitation • Known history of anaphylaxis or reactions to parenteral iron • Known state of iron overload Arch Gynecol Obstet. 2017 Dec;296(6):1229-1234
  • 20. Iron Oxyhydroxide core Carbohydrate shell – stabilizes the molecule and slows release of elemental iron Parenteral Iron Preparations
  • 21. Iron Dextran Risk of anaphylaxis Iron Sucrose Multiple doses; longer time of administration Ferric Carboxymaltose High amount of iron in single dose with low risk of hypersensitivity reactions Iron Isomaltoside Contains reduced dextran, more labile iron v/s FCM, Low clinical evidence Parenteral iron Selecting Ideal Parenteral Iron
  • 22. Property Ideal Iron dextran Iron sucrose Ferric carboxymaltose Type I (robust) I (robust) II (semi-robust) I (robust) Mol wt >100 kD >100 kD 34-60 kD 150 kD Complex stability High High Moderate High Half life Long 3-4 days 6 hours 16 hours pH Neutral Neutral High Near-Neutral Osmolality Isotonic Isotonic High Isotonic Antigenicity Low High Low Low Test dose No Yes No No Time for injection Short 4 - 6 h for 20mg/kg 3.5 h for 7mg/kg 15 min for 1000mg Max dose High 20mg/kg 600 mg/week 1000 mg/infusion Arzneimittelforschung 2010;60(6a):345–353; Arzneimittelforschung 2010;60(6a):399–412 Properties of an Ideal Parenteral Iron
  • 23. Critical Attributes of FCM Type 1 (robust) Parenteral iron Not associated with dextran-induced hypersensitivity Can be administered in much higher doses Short infusion time (minimum 15 minutes) Iron is released slowly, avoiding toxicity and oxidative stress Structure similar to ferritin, deposited easily in RE cells Test dose is not required Low immunogenic potential Qualities of FCM are best suited for real-life clinical usage
  • 24. FCM – Dosage Calculation and Administration In most of Indian pregnant women 1000 to 1500 mg is well suited Ferric carboxymaltose summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5910/smpc/print
  • 25. Administration of FCM in Routine Clinical Practice Dilution Duration Ferric carboxymaltose summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc/product/5910/smpc/print • Mix Inj FCM 1000mg in 250 ml of saline and give over 15 minutes • Mix inj FCM 500mg in 100ml of saline and give over 6 minutes • Monitor Vitals for 45 minutes
  • 26. Clinical Evidence: FCM in Management of IDA During Pregnancy
  • 27. Global Evidence of FCM in Pregnancy Geography Total no. of studies Countries No. of pregnant women treated with FCM Highest Hb rise (g/dL) Highest Ferritin rise (µg/L) Global Studies Ten (#10) Switzerland, United Kingdom, Australia, Spain, Korea, Australia, UAE, Turkey 2495 3.6 188 Indian Studies Seventeen (#17) India 1326 5.5 180 Current evidence highlighted data of FCM usage in 3821 pregnant women with maximum Hb rise of 5.5 g/dL and ferritin rise of 180 µg/L Naqash A et al. BMC Womens Health. 2018; 18(1):6 Jose et al. BMC Pregnancy and Childbirth (2019) 19:54
  • 28. Important Clinical Studies of FCM in Pregnancy Sr. no. Study Patient population In FCM group Follow Up (Weeks) Hb rise (g/dL) Ferritin rise (µg/L) Any Serious Adverse Event 1 Maheshwari et al 100 4 3.6 47 No 2 Mishra et al 108 3 2.1 168 No 3 Naqash et al 100 4 5.5 31 No 4 Agrawal et al 50 3 3 65 No 5 Gandotra et al 100 2 2.9 65 No 6 Mahaur et al 50 6 2.6 112 No 7 Patel et al 50 3 2.6 101 No 1. Maheshwari et al. Indian J Obstet Gynecol Res. 2017;4(1):96-100. 2. Mishra V et al. Journal of Nepal Health Research Council. 2017 Sep 8;15(2):96-9 3. Naqash A et al. BMC Womens Health. 2018; 18(1):6 4. Agrawal D et al. J Reprod Contracept Obstet Gynecol. 2019 Jun;8(6):2280-2285 5. Gandotra N et al. Int J Res Med Sci. 2020 Oct;8(10):3539-3542 6. Mahaur et al. International Journal of Clinical Obstetrics and Gynaecology 2020; 4(3): 148-152 7. Patel A et al. Int J Reprod Contracept Obstet Gynecol. 2020 Jun;9(6):2437-2441
  • 29. Inclusion Criteria Intervention Parameters RCT 100 Pregnant women diagnosed with moderate to severe IDA FCM (n=50): Dose as per calculated iron requirement Iron Sucrose (ISC) (n=50): Dose as per calculated iron requirement Rise in Hb from baseline after 12 weeks Jose et al. BMC Pregnancy and Childbirth (2019) 19:54 Indian RCT from AIIMS, New Delhi
  • 30. Rise in hemoglobin at 12 weeks from baseline Jose et al. BMC Pregnancy and Childbirth (2019) 19:54 • Treatment with FCM resulted in rapid replenishment of iron stores with significantly higher Hb rise over a 12 week period. • Convenient dosing with lesser number of total doses to complete the treatment will lead to better compliance Indian RCT from AIIMS, New Delhi: Results The mean rise in Hb at 12 weeks was significantly higher in FCM group than Iron Sucrose group (29 g/L vs 22 g/L; p < 0.001)
  • 31. Insights from Indian Real World Evidence 50 pregnant women in 2nd and 3rd trimester received a single IV infusion of FCM 1000 mg over 15 minutes Significant increase in Hb of 2.24 g/dl over 4 weeks Significant improvement in fatigue score at 4 weeks International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2021 Dec 1;10(12):4402-7.
  • 32. Insights from Largest Indian Real World Evidence Indian real world evidence of 271 pregnant women receiving FCM of ~1000 mg Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
  • 33. • 271 pregnant women in 2nd and 3rd trimester of pregnancy received FCM (Mean dose ∼1000 mg) • Significant increase in Hb was noted in just 20 days! • Significant increase in Hb of 4.23 g/dL was noted in Severe Anemia Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470. Insights from Largest Indian Real World Evidence: Efficacy Single large dose administration of FCM led to rapid rise of Hb in moderate-to-severe anemia during pregnancy in a real-life scenario.
  • 34. Insights from Largest Indian Real World Evidence: Safety • Adverse events reported in just 4% of pregnant women! (Most common – rash and itching) • No hypersensitivity reactions observed in any pregnant women • Continuous monitoring of vitals and oxygen saturation up to 45 min did not report any negative safety signals Absence of any hypersensitivity reactions and no negative safety signal in vital parameters observed during continuous monitoring supports excellent safety of FCM in moderate-to-severe anemia during pregnancy in a real-life scenario Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
  • 35. • Data of 162 newborns born to mothers who had received FCM in pregnancy was analyzed in terms of: • Mean gestational age at delivery • Mean birth weight • Apgar score • Stillbirth, perinatal, and early neonatal mortality rates • Requirement of hospitalization No adverse effects in terms of perinatal and neonatal outcomes were observed in newborns of women who received FCM during pregnancy Insights from Largest Indian Real World Evidence: Neonatal Outcomes Gupte et al, J Obstet Gynaecol Res. 2021 Oct;47(10):3464-3470.
  • 36. Global Clinical Studies: FCM and Neonatal Outcomes Christoph et al. Journal of perinatal medicine. 2012 Sep 1;40(5):469-74 • 206 pregnant women: Treated either with FCM or iron sucrose • Among women treated with FCM, no signs of negative effects of the FCM treatment were detected on the fetus or newborn babies. • 95 pregnant women: Treated with FCM; 83 women among them received single dose of FCM 1000mg • Neonatal outcomes (week of pregnancy at delivery, Apgar scores, and birth weight) were NOT adversely affected due to FCM Aporta Rodriguez et al. Obstetrics and gynecology international. 2016 Jan 1;2016
  • 37. Global Clinical Studies: Neonatal Outcomes Breymann et al. Journal of perinatal medicine. 2017;45(4):443-53 • 126 pregnant women: Treated with FCM (1000 – 1500 mg) • No complications associated with FCM treatment of the mothers were evident in the newborns • 83 pregnant women: Treated with FCM (1000 mg single dose) • FCM administered to pregnant women did not affect fetal outcomes (Apgar scores, weight, length or head circumference of the baby, neonatal resuscitation or complications) Khalafallah A et al. InSeminars in hematology. 2018; 55(4):223-234
  • 38. Mild anemia (Hb 10-10.9g/dL) & Moderate anemia ( 7-9.9 g/dL) First level of treatment Two tablets of iron and folic acid tablet (100 mg elemental iron and 500 mcg folic acid) daily for 6 months Parental iron (IV Iron Sucrose or FCM) may be considered as the first line of management in pregnant women who are detected to be anemic late in pregnancy or in whom compliance is likely to be low (high chance of lost to follow- up). If no improvement, after first level of treatment • Referral to higher health facility • The case may be managed with IV Iron Sucrose/Ferric Carboxymaltose Anemia Mukt Bharat Guidelines 2018 Anemia management protocol for Pregnant women
  • 39. Severe anemia (Hb 5-6.9 g/dL) First level of treatment Immediate hospitalization if it is the third trimester of pregnancy where round-the-clock specialist care is available The treatment will be done using IV Iron Sucrose/Ferric Carboxymaltose by the medical officer. Anemia Mukt Bharat Guidelines 2018 Anemia management protocol for Pregnant women
  • 40. FCM in Management of IDA in Pregnancy: Conclusion • FCM is superior to oral iron and other IV irons in terms of speed and absolute extent of rise in hemoglobin and replenishment of iron stores • FCM administration does not require test dose; not associated with dextran-induced hypersensitivity; can be administered safely in a higher dose in short duration • FCM infusion during pregnancy is not associated with severe hypersensitivity reactions and negative safety signals in vital parameters • Substantial Global and Indian evidence encompassing 3821 pregnant women with maximum Hb rise of 5.5 g/dL and ferritin rise of 180 µg/L • FCM administered to pregnant women for treatment of IDA did not adversely affect neonatal outcomes (Apgar score, birth weight, mortality rates, hospitalization rates, etc.)

Editor's Notes

  1. FOGSI General Clinical Practice Recommendations.Management of Iron Deficiency Anemia in Pregnancy.India;2017 These requirements are unlikely to be met by the diet alone because of poor accessibility, availability, and affordability of diversified food. Hence, regular iron supplementation is necessary for pregnant women to prevent IDA
  2. Currently available formulations are iron-carbohydrate complexes or colloids based on small spheroidal particles, each consisting of a core of iron surrounded by a carbohydrate shell; the latter stabilizes the molecule and slows the release of elemental iron